VIS-624

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameVIS-624

Drug Alias NameVIS624

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionTumor necrosis factor ligand superfamily member 13 inhibitorsImmunomodulators

TargetsTumor necrosis factor ligand superfamily member 13

Therapy Area/IndicationsMultiple Myeloma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesVisterra Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesVisterra Inc

Active IndicationsN/A

Inactive IndicationsMultiple Myeloma

ATC CodeN/A